Giuseppe Murdaca
Giuseppe Murdaca, MD
Assistant Professor of Internal Medicine
  • :+39-010-3537924
  • :+39-010-5556950

University of Genova
Italy

Education

  • 1993  M.D. Degree, cum laude, University of Genova

Biography

Dr. Giuseppe Murdaca has received his PhD in Science and Space Engineering at the University of Genova (Italy) during the period of 2000-2003. Currently, he is working as Assistant professor in Internal Medicine University of Genova (Italy). He is an Editorial board member for various international journals. He is a member in international societies. Based on this research and fellowship training he has received several awards and honors, such as: Prize for young researchers of the study, assigned by the GILS and award for one of the three best oral presentations at the Ninth Congress of the Inter-SIMI Piemonte and Valle D'Aosta, Liguria (Genoa, 06.17.2004). Murdaca G., Fenoglio D., M. Setti, Brenci S., Villa R., Pontali E., A. Kunkl, Indiveri F., Puppo F. "Generation of CD4 + lines specific for Pneumocystis carinii and Candida albicans obtained from HIV + patients. Meaning of the coexpression of IFN- and IL-4”.

Research Interest

  • Immunodeficiency
  • Autoimmunity
  • Neuro-endocrino-immunology
  • Pharmacogenomics

 

Professional Activities:

Specialty certifications

  • 1999     Allergology and Clinical Immunology, University of GenoVa
  • 2003     PhD

Professional experience

  • 1996-1999  Fellow- Allergology and Clinical Immunology
  • 2006   Assistant Professor-Internal Medicine

Membership

  • Italian Society of Immunology, Clinical Immunology and Allergy
  • Italian Society of Internal Medicine
  • Italian Society of Experimental Biology

 

Publications

  1. Sa1729 Expression of Epidermal Growth Factor Receptor in Patients With Gastro-Oesophageal Reflux Disease and in Those With Systemic Sclerosis Patrizia Zentilin,Elisa Marabotto, Lorenzo Assandri, Luca Mastracci,Federica Grillo, Giuseppe Murdaca,Alberto Sulli, Edoardo Savarino, Vincenzo Savarino ·
  2. Mo1123 Oesophageal Intraluminal Baseline Impedance Levels in Patients With Non-Erosive Reflux Disease and in Patients With Systemic Sclerosis Patrizia Zentilin · Elisa Marabotto · Giuseppe Murdaca · Alberto Sulli · Edoardo Savarino · Vincenzo Savarino ·
  3. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study. Amanda Mocroft · Jens D Lundgren · Michael Ross · Matthew Law · Peter Reiss · Ole Kirk · Colette Smith · Deborah Wentworth · Jacqueline Neuhaus · Christoph A Fux · [...] · S. Weissman · A. Wilkin · J. Witter · L. Wojtusic · V. Yeh · B. Young · C. Zeana · J. Zeh · E. Savio · M. Vacarezza.
  4. Infection risk associated with anti-TNF-α agents: A review Giuseppe Murdaca · Francesca Spanò · Miriam Contatore · Andrea Guastalla · Elena Penza · Ottavia Magnani · Francesco Puppo.
  5. Pharmacogenetics and Future Therapeutic Scenarios: What Affects the Prediction of Response to Treatment with Etanercept? Giuseppe Murdaca · Rossella Gulli · Francesca Spanò · Paola Mandich · Francesco Puppo ·
  6. Seminars in Research 2013 Paolo Gisondi · Giuseppe Murdaca.
  7. Pharmacogenetics of etanercept: Role of TNF-α gene polymorphisms in improving its efficacy Giuseppe Murdaca · Francesca Spanò · Miriam Contatore · Andrea Guastalla · Ottavia Magnani · Francesco Puppo.
  8. Efficacy and safety of etanercept in chronic immune-mediated disease Giuseppe Murdaca · Francesca Spanò · Miriam Contatore · Andrea Guastalla · Ottavia Magnani · Francesco Puppo ·
  9. TNF-α Gene Polymorphisms: Association with Disease Susceptibility and Response to Anti-TNF-α Treatment in Psoriatic Arthritis Giuseppe Murdaca · Rossella Gulli · Francesca Spanò · Francesca Lantieri · Martina Burlando · Aurora Parodi · Paola Mandich · Francesco Puppo ·
  10. Potential use of TNF-α inhibitors in systemic sclerosis Giuseppe Murdaca · Francesca Spanò · Miriam Contatore · Andrea Guastalla · Francesco Puppo ·
  11. Current therapies for the treatment of systemic sclerosis-related pulmonary arterial hypertension: Efficacy and safety Giuseppe Murdaca · Francesca Spanò · Francesco Puppo ·
  12. Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: Current views upon safety and immunogenicity Giuseppe Murdaca · Andrea Orsi · Francesca Spanò · Francesco Puppo · Paolo Durando · Giancarlo Icardi · Filippo Ansaldi ·
  13. Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis Giuseppe Murdaca · Francesca Spanò · Francesco Puppo ·
  14. Free radicals and endothelial dysfunction: Potential positive effects of TNF-α inhibitors Giuseppe Murdaca · Francesca Spanò · Paola Cagnati · Francesco Puppo ·
  15. A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer Daniela Fenoglio · Paolo Traverso · Alessia Parodi · Laura Tomasello · Simone Negrini · Francesca Kalli · Florinda Battaglia · Francesca Ferrera · Stefania Sciallero · Giuseppe Murdaca · Maurizio Setti · Alberto Sobrero · Francesco Boccardo · Giuseppe Cittadini · Francesco Puppo · Domenico Criscuolo · Giorgio Carmignani · Francesco Indiveri · Gilberto Filaci ·

 

 

Autoimmune Journal Flyer